Table 1. Patient characteristics.
| Data | |
|---|---|
| Sex, n (%) | |
| Female | 69 (43) |
| Male | 90 (57) |
| Race, n (%) | |
| White | 128 (81) |
| Black | 14 (9) |
| Asian | 8 (5) |
| Other | 9 (6) |
| Age at RT, y | |
| Median | 4.0 |
| Range | 1.2-17.9 |
| Primary site location, n (%) | |
| Adrenal | 124 (78) |
| Central abdominal compartment | 28 (18) |
| Mediastinum and/or thorax | 7 (4) |
| MYCN, n (%) | |
| Nonamplified | 87 (55) |
| Amplified | 62 (39) |
| Unknown | 10 (6) |
| Shimada histopathology, n (%) | |
| Favorable | 8 (5) |
| Unfavorable | 111 (70) |
| Unknown | 40 (25) |
| Metastatic sites, n (%) | |
| Bone only | 76 (48) |
| Soft tissue only | 9 (6) |
| Bone and soft tissue | 74 (47) |
| Stem cell transplantation, n (%) | |
| Yes | 54 (34) |
| No | 105 (66) |
| MIBG therapy, n (%) | |
| Yes | 20 (13) |
| No | 139 (87) |
Abbreviations: MIBG = metaiodobenzylguanidine; RT = radiation therapy.